BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. - Wikidata - wikimedia - TriplyDB

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

http://www.wikidata.org/entity/Q30967043

about

B-Raf and the inhibitors: from bench to bedside Main roads to melanoma Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis B-Raf specific antibody responses in melanoma patients Clinical significance of BRAF mutations in metastatic melanoma Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomy Circulating serologic and molecular biomarkers in malignant melanoma NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.Genetics of melanocytic nevi Cell cycle gene networks are associated with melanoma prognosis Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organization Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.Melanoma genetics and the development of rational therapeutics.Biologically distinct subsets of nevi A phase II trial of sorafenib in metastatic melanoma with tissue correlates.The Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN Circuit Clinical correlates of NRAS and BRAF mutations in primary human melanoma.Insulin-like growth factor system and sporadic malignant melanoma.Melanoma: Molecular Pathogenesis and Therapeutic Management Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/IPMC) of the pancreas Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma.BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article.Revisiting determinants of prognosis in cutaneous melanoma.The p38 MAPK stress pathway as a tumor suppressor or more?Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression Skp2 regulates G2/M progression in a p53-dependent manner Issues affecting molecular staging in the management of patients with melanoma Targeted therapy in cancer.Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor.

P2860

Q21198860-EE281C4D-2621-40AB-82FB-D260FF2E2542 Q21245465-6863083F-177D-4085-B48A-7A6E615BF32A Q24791830-81713208-DC81-47A1-B463-61C480A13C83 Q24794587-1DB50F25-191F-427C-8FC9-5014DD9FD5E4 Q24803115-917341C6-0D56-4D81-8B71-E4BFEB240120 Q24814098-3707F4A0-0540-4E26-81D0-E046F5D3EB58 Q26740135-A639D7F7-E848-40E0-9691-A43D453F20B2 Q27020946-7F015F72-4000-4159-9651-5587CD9AAC24 Q27852445-46992460-6202-46AA-BF00-E96B83EA8F3E Q28085036-EAA2D16C-D2AC-4FB4-AA07-34594518D305 Q28482466-CCE05B58-8DF3-4E65-ACC6-3A81B920CEDB Q28740547-457E96DB-5716-4D18-93A4-4BFD10BF99D5 Q30443185-2F6F571B-6DD7-4740-979E-F961A85959AD Q31096247-6EA3A033-4F86-4744-9767-5FA457A447DC Q33387548-4B717B8C-5891-491B-BFEC-E6F841E4237F Q33647719-130DDCB0-A321-4645-9025-A3E6E110EC91 Q33725172-DB0CB294-DD67-43D2-8A0B-E79774F3A02B Q33726956-02284CDE-4225-4402-9006-21EF0B7077F0 Q33731436-7852EB8A-5A7D-479E-BCE6-D78C52F36F1D Q33785790-8B3BDF7D-5C18-43D1-8AA7-C4DAB06BDFFF Q34106285-A303A901-C8A8-460E-9FBD-45799CA91986 Q34500495-700BF4DF-B1AB-4E4D-8954-32BA5B797A4A Q34756364-45497A6F-ABEF-426C-9F69-44D738522DEE Q35137163-A338F177-6F4E-41BE-902A-313BC765E270 Q35229797-40FF50B3-856B-4FE5-9947-2EE6EE0ED74F Q35588657-48F7A5AC-9BF7-4070-8D54-8B08A9C0071F Q35607456-6FB60F72-2FA9-44C9-BCE5-C4D2D21662AA Q35783104-E6CF41B0-98AC-412B-93D6-E972FF736D87 Q35789640-BD360F0D-EBCE-4E5B-8DB7-3B2725260FCA Q36154050-CC4C8FD9-2C08-4596-A663-4C8E4186A4DC Q36338825-2B74B9DE-1BB8-4A96-B67D-99770EDA3ED0 Q36592365-EBBF7101-7D83-4440-A18F-6FAC3F4489A5 Q36615986-25DB4765-2A06-4672-957B-72FD657C68C3 Q36784394-8619D802-E419-4C5B-B641-7F874F438866 Q36954187-E5DC9A4C-1BC1-47AD-A493-CFF9BB050902 Q36990701-CBB0A599-68F4-497F-AC93-B2BDADC17BF4 Q37204270-2FF664B2-47CE-4519-8E00-DE079296E964 Q37286893-A621540D-86C4-4059-A50E-EA1CAE62F0F9 Q37396826-DD3B13D8-3C07-4D5E-AF1F-378BC96E1083 Q37420174-603B5272-669A-4568-A865-8740EF226B8F

P2860

BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.

http://www.wikidata.org/entity/Q30967043

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

BRAF oncogenic mutations corre ...... initiation of human melanoma.

@ast

BRAF oncogenic mutations corre ...... initiation of human melanoma.

@en

type

label

BRAF oncogenic mutations corre ...... initiation of human melanoma.

@ast

BRAF oncogenic mutations corre ...... initiation of human melanoma.

@en

prefLabel

BRAF oncogenic mutations corre ...... initiation of human melanoma.

@ast

BRAF oncogenic mutations corre ...... initiation of human melanoma.

@en

P1433

Q30967043-F2F6B051-18BA-464A-A3EB-7FAD2BA7026D

P1476

Q30967043-925DDD07-8E05-45D5-8477-FBD81506D750

P2093

Q30967043-0C2AFB3F-82AC-4DA0-B2BE-7E29E359D334

Q30967043-25CE6C38-51A1-436A-843C-9A95B0F1A81B

Q30967043-5A0B12FC-489C-48D0-8CA3-CA153E493739

Q30967043-79890FD5-AD35-415B-B911-4599DBD65AF3

Q30967043-96C84853-E45E-458E-8050-4388A4364E2C

Q30967043-CFD77776-AB3A-4C5B-8032-62ED489C6103

Q30967043-D7F01218-2C09-4898-9C4D-768BA514C437

P304

Q30967043-E16B2466-E4F6-477E-8FA1-AEFCF2958E8D

P31

Q30967043-8166C6B1-7D39-4287-A756-BAB7961676E0

P407

Q30967043-B7249648-43E3-4717-8EFD-6DE19560E06E

P433

Q30967043-AFAA2DB0-D705-407F-8FB0-968684394DE2

P478

Q30967043-8EE7B7FB-05A0-45C7-9FA3-86B90735CD09

P577

Q30967043-C4C75492-8610-450B-AA60-9AB857ED00DB

P698

Q30967043-4CF20200-27EA-4BA2-AB43-6245F0F954C3

P1433

Cancer Research

P1476

BRAF oncogenic mutations corre ...... n initiation of human melanoma

@en

P2093

Jianli Dong

http://www.w3.org/2001/XMLSchema#string

Outhiriaradjou Benard

http://www.w3.org/2001/XMLSchema#string

Robert G Phelps

http://www.w3.org/2001/XMLSchema#string

Rui Qiao

http://www.w3.org/2001/XMLSchema#string

Shen Yao

http://www.w3.org/2001/XMLSchema#string

Stuart A Aaronson

http://www.w3.org/2001/XMLSchema#string

Zeev Ronai

http://www.w3.org/2001/XMLSchema#string

P304

3883-3885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12873977

http://www.w3.org/2001/XMLSchema#string